Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 91.84
0.207 %
$ 114 B
Market Cap
20.73
P/E
GILD - COST OF REVENUE
Cost of Revenue GILD - Gilead Sciences, Inc.
6.5 B
LAST VALUE
-0.78%
2 YEAR CAGR
6.01%
5 YEAR CAGR
8.56%
10 YEAR CAGR